Kiper Christopher S
Transaction: 06/04/2026
BUY
Change
+25,907
Price
Not reported
Filing
06/08/2026
Type
BUY
Lifecore Biomedical, Inc.
LFCR • Drug Manufacturers - Specialty & Generic
$6.38
▲ +0.01 (+0.16%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$239.11M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 3.49Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:39 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$6.38
Change0.16%
Shares Out37.48M
Market Cap$239.11M
Enterprise Value$361.78M
52W Range3.63 - 8.98
Beta1.06
P/E-7.77
P/S1.85
P/B11.51
P/FCF38.38
EV/Sales2.79
Price$6.38
Change0.16%
Shares Out37.48M
Market Cap$239.11M
Enterprise Value$361.78M
52W Range3.63 - 8.98
Beta1.06
P/E-7.77
P/S1.85
P/B11.51
P/FCF38.38
EV/Sales2.79
EV/EBITDA30.16
EV/FCF58.07
Earnings Yield-12.88%
FCF Yield2.61%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-10.04
Current Ratio3.49
Quick Ratio2.26
Revenue 5Y-100.00%
Target$6.39
Target Upside0.16%
Target Median$6.39
Target Range6.28 - 6.50
Volume2.84K
Avg Volume200.58K
EPS Surprise-0.19
Investment DNA
How strong this company looks for long-term investors
31
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Healthy liquidity · 3.49Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-10-20
75/100
Bullish
Bullish
4
Hold
4
Bearish
0
Price Target
2026-08-07
Low
$6.50
Mean
$6.50
Median
$6.50
High
$6.50
Insider Transactions
Recent executive and insider activity
HOUDE LOVAS KATRINA
Transaction: 06/04/2026
BUY
Change
+25,907
Price
Not reported
Filing
06/05/2026
Type
BUY
Johnson Paul Harold
Transaction: 06/04/2026
BUY
Change
+25,907
Price
Not reported
Filing
06/05/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Kiper Christopher S | BUY | +25,907 | Not reported | 06/04/2026 | 06/08/2026 |
| HOUDE LOVAS KATRINA | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Johnson Paul Harold | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Antunes Humberto Calheiros | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Korenberg Matthew E | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Schechter Joshua | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Aryeh Jason | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| OBUS NELSON | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Josephs Paul | SELL | -40,413 | $4.57 | 05/20/2026 | 05/21/2026 |
| Salus Thomas D. | SELL | -24,645 | $5.20 | 04/14/2026 | 04/16/2026 |
| Salus Thomas D. | BUY | +30,000 | Not reported | 03/02/2026 | 03/02/2026 |
| Lake Ryan David | SELL | -22,932 | $7.71 | 09/03/2025 | 09/04/2025 |
| HOUDE LOVAS KATRINA | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Schechter Joshua | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Antunes Humberto Calheiros | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Korenberg Matthew E | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Aryeh Jason | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Johnson Paul Harold | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Kiper Christopher S | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| OBUS NELSON | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |